February 13, 2014
I was discussing the underlying causes of Alzheimer’s disease with a colleague today, while at RoxSpa Newport Beach, and came across this article, also posted today, making the association between the pesticide DDT and the production of amyloid plaques in Alzheimer’s patients. Though DDT was banned from use in the US in 1972, other countries continue to use it and consequently the chemical still finds its way into our cells. I’ve taught physicians about the association between DDT and breast cancer in continuing medical education lectures through the American College for Advancement in Medicine and the American Nutraceutical Association over the years but this is the first reference I’ve seen making a possible connection to this pesticide’s detrimental effects on the brain. Read more here.
October 4, 2012
A new study raises concern about the effects of BPA on thyroid hormone levels in pregnant women and in young boys. BPA is found in plastic bottles, the lining of food and beverage cans, dental sealants and even in sales receipts. Originally BPA was found to cause harmful synthetic estrogen-like effects. Now we are learning that it impacts one of the most critical hormone groupings in pregnant women and children. I teach physicians about testing newly pregnant women at a very specific time, for thyroid hormone levels (including TSH, Free T3, Free T4 and TPO Antibodies) because if left untreated, an imbalance in these hormones will lead to recurrent miscarriage, difficulty producing breast milk, and serious developmental challenges in a newborn.
April 19, 2012
Join PharmCon’s pharmaceutical webinar series on “Innovative Strategies for Optimizing Thyroid Function” on April 23rd at 10:30 AM EST with Dr. Gina Cushman, NMD, PhD, founder of HealthBridge Management LLC and HealthBridge Medical Center in Newport Beach, CA.
Dr. Cushman will be discussing the benefits and appropriate use of the various thyroid medications available to healthcare practitioners, and a new approach to the diagnosis and treatment of thyroid-related imbalance.
AMA and ACPE approved for 1.25 live pharmaceutical continuing medical education credits. Cost is free to members (nominal $50 annual fee for unlimited access to live CMEs) and $30 to non-members.